PT-141 — Research Peptide (Lyophilised, HPLC ≥99%)

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide supplied as a sterile lyophilised powder for in-vitro laboratory investigation of melanocortin receptor subtypes (MC1R, MC3R, MC4R). Each batch is characterised by reversed-phase HPLC (≥99%) and identity-confirmed by mass spectrometry; a per-batch Certificate of Analysis is issued with every shipment.

Specifications

• Purity: ≥99% (RP-HPLC)
• Identity: MS-verified
• Form: Lyophilised powder, sealed vial
• Storage: −20 °C, protected from light
• Manufacturer: Oxford Research Syndicate Ltd
• Batch / Lot: supplied on COA

For in-vitro laboratory research use only. Not a medicinal product. Not for human, veterinary, diagnostic, therapeutic or in-vivo use. Not for resale to the general public.